1. Emergency First-Line Anti-Seizure Medication for Seizures and Status Epilepticus: What is Going Wrong, Doctor?

   • Raoul Sutter

   Commentary 31 August 2018 Pages: 891 - 893

2. Potential Role of Selective Serotonin Reuptake Inhibitors in Improving Functional Outcome after Stroke

   • Janne Kaergaard Mortensen
   • Grethe Andersen

   Leading Article 17 September 2018 Pages: 895 - 903

3. Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis

   • Simona Lattanzi
   • Francesco Brigo
   • Mauro Silvestrini

   Systematic Review 21 August 2018 Pages: 905 - 916

   

4. Antipsychotic-Associated Symptoms of Tourette Syndrome: A Systematic Review

   • David D. Kim
   • Alasdair M. Barr
   • Ric M. Procyshyn

   Systematic Review 18 August 2018 Pages: 917 - 938

   

5. Cancer Risk in Patients with Multiple Sclerosis: Potential Impact of Disease-Modifying Drugs

   • Christine Lebrun
   • Fanny Rocher

   Review Article 24 August 2018 Pages: 939 - 949

   

6. Palliative Sedation for the Terminally Ill Patient

   • Ferdinando Garetto
   • Ferdinando Cancelli
   • Marco Maltoni

   Review Article 27 September 2018 Pages: 951 - 961

   

7. Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study

   • Massimiliano Mirabella
   • Luca Prosperini
   • Carlo Pozzilli

   Original Research Article 18 July 2018 Pages: 963 - 970

   

8. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson’s Disease?

   • Seok Jong Chung
   • Han Soo Yoo
   • Phil Hyu Lee

   Original Research Article 19 July 2018 Pages: 971 - 979